| Tap a line for its trend | Currentlast close | FY22Mar 2022 |
|---|
| 83.1 | — | |
| 0.9 | 0.9 | |
| 4.0 | 4.0 | |
| 86.2 | — | |
| 2.4 | 2.4 | |
| −2.9 | −2.9 | |
| −120.3% | −120.3% | |
| −2.9 | −2.9 | |
| 4.4 | 4.4 | |
| 179.6% | 179.6% | |
| ₹16.98 | ₹16.98 | |
| −3.2 | −3.2 | |
| −3.2 | −3.2 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY22 31/03/2022 | Current last close | |
|---|---|---|---|
| Market Capitalization | — | 83.1 | |
| - Cash, Equiv & ST Investments | 0.9 | 0.9 | |
| + Total Debt | 4.0 | 4.0 | |
| Enterprise Value | — | 86.2 | |
| Revenue | 2.4 | 2.4 | |
| EBITDA | -2.9 | -2.9 | |
| Margin % | -120.33 | -120.33 | |
| EBIT | -2.9 | -2.9 | |
| Net Income | 4.4 | 4.4 | |
| Margin % | 179.59 | 179.59 | |
| EPS, Adj (current shares) | 16.98 | 16.98 | |
| Cash from Operations | -3.2 | -3.2 | |
| Free Cash Flow | -3.2 | -3.2 | |
Figures from the company's filings with NSE
In FY22 its consolidated net profit was ₹4.4 crore on revenue of ₹2.4 crore. Its debt-to-equity ratio was 0.10 on 31 March 2022.
No. Cravatex had borrowings of ₹4 crore on 31 March 2022 (consolidated balance sheet), a debt-to-equity ratio of 0.10. Its cash and current investments were ₹93 lakh, so its net debt was ₹3.1 crore.
Cravatex's debt-to-equity ratio was 0.10 on 31 March 2022: borrowings of ₹4 crore against total equity of ₹42.2 crore.
In FY22, Cravatex generated ₹3.2 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹3.2 crore. In FY19 it was −₹1.2 crore.
Cravatex's net worth — shareholders' equity in its consolidated balance sheet — was ₹42.2 crore on 31 March 2022.
Cravatex's book value per share was ₹163.17 on 31 March 2022: shareholders' equity of ₹42.2 crore divided by the 25.84 lakh shares in issue.
In 2026, Cravatex has declared one dividend: ₹13 (final) with record date 24 July 2026.
In FY22, Cravatex's return on equity (ROE) was 10.4% and its return on capital employed (ROCE) was −5.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Cravatex's basic earnings per share (EPS) were ₹16.98 in FY22, against ₹8.76 in FY19.
In FY22 (April 2021–March 2022), Cravatex's consolidated net profit was ₹4.4 crore, up 93.8% from ₹2.3 crore in FY19, on revenue from operations of ₹2.4 crore (up 135.1%).
From Cravatex's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.